This article was originally published in Media Planet UK on November 18, 2019. 700,000 people around the world, who die each year through antimicrobial resistant (AMR) infections, would be on the minds of many during this year’s World Antibiotic Awareness Week. AMR is a global health emergency caused by the overuse and misuse of antibiotics. ...
Read moreThis article was originally published (in German) in Neue Zürcher Zeitung (NZZ) on November 14, 2019. Antimicrobial resistance: A ticking time bomb The more indiscriminate antibiotics are used in everyday medical practice, the higher the likelihood that they will lose their effect. Pathogenic bacteria are enormously adaptable. If we want to win the fight against them, investment...
Read moreThis blog was originally published on Pharma Boardroom on 12 November 2019 Last week I had the pleasure of moderating a panel discussion on access to medicines at the World Health Summit (WHS) in Berlin. The session brought together a panel of public health leaders from diverse sectors, specialities and geographies to discuss challenges and...
Read moreLast month I sat down with Michael McKay from the WRS to discuss the biopharmaceutical industry and its role, opportunities and challenges in this very complex world of health. As I was telling him during our lengthy conversation, the biopharmaceutical industry is responsible for a lot of what has changed in our lives in the...
Read moreThis article was originally published (in German) in the print edition of Frankfurter Allgemeine Zeitung (FAZ) on October 29, 2019. Progress in discovering new antibiotics is imperative Boosting R&D to fight superbugs: getting the risk-reward ratio right Fifty years ago, the global health community thought it had won the war against infectious diseases through antibiotics....
Read moreThis article was originally published in the Financial Times on October 30, 2019. Rich countries must pay more to achieve health for all in poorer countries Trade association chief argues the case for differentiated pricing If you live on as little as $2 a day, even finding 20 cents for a blood test, a hospital...
Read moreReliance is an act whereby a regulatory authority (NRA) in one jurisdiction may take into account and give significant weight to – i.e. totally or partially rely upon – evaluations performed by another regulatory authority or other trusted institution in reaching its own decision. The relying authority remains responsible and accountable for decisions taken, even...
Read moreThis blog was originally published on Health Policy Watch on 25 October 2019. As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on...
Read moreGlobal Health Progress is a new knowledge hub highlighting over 200 collaborations between the innovative biopharmaceutical industry and more than 850 partners to support the SDGs. Users can explore collaborations by SDG target, disease area, program strategy, and more. Users are also encouraged to connect with partners via the platform to drive new collaborations in...
Read moreGlobal Health Progress is a new knowledge hub highlighting over 200 collaborations between the innovative biopharmaceutical industry and more than 850 partners to support the SDGs. Users can explore collaborations by SDG target, disease area, program strategy, and more. Users are also encouraged to connect with partners via the platform to drive new collaborations in...
Read more